神经科指南

订阅

MedSci主页 / 所有栏目 / 神经科指南

帕金森病运动处方专家共识

2021-12-16 上海中西医结合学会慢性神经系统疾病专业委员会 同济大学学报(医学版)

帕金森病运动疗法老年神经科

帕金森病(Parkinson’s disease, PD)患者在各个时期均会出现不同程度的运动症状和非运动症状。

中文标题：

帕金森病运动处方专家共识

发布机构：

上海中西医结合学会慢性神经系统疾病专业委员会

发布日期：

2021-12-16

简要介绍：

帕金森病(Parkinson’s disease, PD)患者在各个时期均会出现不同程度的运动症状和非运动症状。运动干预有助于改善PD症状。PD运动处方专家共识写作组参阅最新循证文献,依据FITT-VP运动处方制定原则,秉承“持之以恒、动之有方”的运动理念,充分考虑临床适用性形成该共识,以期为临床医师制定PD运动方案提供参考。 

相关资料下载：
[AttachmentFileName(sort=1, fileName=帕金森病运动处方专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=fdd551c0023190be, title=帕金森病运动处方专家共识, enTitle=, guiderFrom=同济大学学报(医学版), authorId=0, author=, summary=帕金森病(Parkinson’s disease, PD)患者在各个时期均会出现不同程度的运动症状和非运动症状。, cover=https://img.medsci.cn/2022112/1641999854604_5579292.jpg, journalId=0, articlesId=null, associationId=2286, associationName=上海中西医结合学会慢性神经系统疾病专业委员会, associationIntro=上海中西医结合学会慢性神经系统疾病专业委员会, copyright=0, guiderPublishedTime=Thu Dec 16 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">帕金森病(Parkinson&rsquo;s disease, PD)患者在各个时期均会出现不同程度的运动症状和非运动症状。运动干预有助于改善PD症状。PD运动处方专家共识写作组参阅最新循证文献,依据FITT-VP运动处方制定原则,秉承&ldquo;持之以恒、动之有方&rdquo;的运动理念,充分考虑临床适用性形成该共识,以期为临床医师制定PD运动方案提供参考。&nbsp;</span></p>, tagList=[TagDto(tagId=337, tagName=帕金森病), TagDto(tagId=3894, tagName=运动疗法), TagDto(tagId=117820, tagName=老年神经科)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=19, categoryName=老年医学, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=13806, appHits=325, showAppHits=0, pcHits=536, showPcHits=13480, likes=4, shares=37, comments=20, approvalStatus=1, publishedTime=Wed Jan 12 22:57:51 CST 2022, publishedTimeString=2021-12-16, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Wed Jan 12 23:00:31 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 12:10:20 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=帕金森病运动处方专家共识.pdf)])
帕金森病运动处方专家共识.pdf
下载请点击：
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1214783, encodeId=e4ef1214e8339, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:07:40 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208818, encodeId=7fa6120881885, content=Very Nice , beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d555283054, createdName=14848e89m65暂无昵称, createdTime=Tue Apr 05 19:39:59 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207291, encodeId=4b47120e291bf, content=好文，学习了👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d3b2210771, createdName=120d521dm50暂无昵称, createdTime=Wed Mar 30 19:09:55 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194684, encodeId=6468119468409, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/485d6988698d6dd918c9b1df896aec0f.jpg, createdBy=5fc45328463, createdName=夏日苍翠, createdTime=Fri Feb 18 05:58:54 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193616, encodeId=d3b0119361668, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d585243593, createdName=光明骑士, createdTime=Tue Feb 15 14:29:24 CST 2022, time=2022-02-15, status=1, ipAttribution=)]
    2022-04-26 su_yi_fei

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1214783, encodeId=e4ef1214e8339, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:07:40 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208818, encodeId=7fa6120881885, content=Very Nice , beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d555283054, createdName=14848e89m65暂无昵称, createdTime=Tue Apr 05 19:39:59 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207291, encodeId=4b47120e291bf, content=好文，学习了👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d3b2210771, createdName=120d521dm50暂无昵称, createdTime=Wed Mar 30 19:09:55 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194684, encodeId=6468119468409, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/485d6988698d6dd918c9b1df896aec0f.jpg, createdBy=5fc45328463, createdName=夏日苍翠, createdTime=Fri Feb 18 05:58:54 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193616, encodeId=d3b0119361668, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d585243593, createdName=光明骑士, createdTime=Tue Feb 15 14:29:24 CST 2022, time=2022-02-15, status=1, ipAttribution=)]
    2022-04-05 14848e89m65暂无昵称

    Very Nice

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1214783, encodeId=e4ef1214e8339, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:07:40 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208818, encodeId=7fa6120881885, content=Very Nice , beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d555283054, createdName=14848e89m65暂无昵称, createdTime=Tue Apr 05 19:39:59 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207291, encodeId=4b47120e291bf, content=好文，学习了👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d3b2210771, createdName=120d521dm50暂无昵称, createdTime=Wed Mar 30 19:09:55 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194684, encodeId=6468119468409, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/485d6988698d6dd918c9b1df896aec0f.jpg, createdBy=5fc45328463, createdName=夏日苍翠, createdTime=Fri Feb 18 05:58:54 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193616, encodeId=d3b0119361668, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d585243593, createdName=光明骑士, createdTime=Tue Feb 15 14:29:24 CST 2022, time=2022-02-15, status=1, ipAttribution=)]
    2022-03-30 120d521dm50暂无昵称

    好文，学习了👍👍👍

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1214783, encodeId=e4ef1214e8339, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:07:40 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208818, encodeId=7fa6120881885, content=Very Nice , beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d555283054, createdName=14848e89m65暂无昵称, createdTime=Tue Apr 05 19:39:59 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207291, encodeId=4b47120e291bf, content=好文，学习了👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d3b2210771, createdName=120d521dm50暂无昵称, createdTime=Wed Mar 30 19:09:55 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194684, encodeId=6468119468409, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/485d6988698d6dd918c9b1df896aec0f.jpg, createdBy=5fc45328463, createdName=夏日苍翠, createdTime=Fri Feb 18 05:58:54 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193616, encodeId=d3b0119361668, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d585243593, createdName=光明骑士, createdTime=Tue Feb 15 14:29:24 CST 2022, time=2022-02-15, status=1, ipAttribution=)]
    2022-02-18 夏日苍翠

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1214783, encodeId=e4ef1214e8339, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:07:40 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208818, encodeId=7fa6120881885, content=Very Nice , beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d555283054, createdName=14848e89m65暂无昵称, createdTime=Tue Apr 05 19:39:59 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207291, encodeId=4b47120e291bf, content=好文，学习了👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d3b2210771, createdName=120d521dm50暂无昵称, createdTime=Wed Mar 30 19:09:55 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194684, encodeId=6468119468409, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/485d6988698d6dd918c9b1df896aec0f.jpg, createdBy=5fc45328463, createdName=夏日苍翠, createdTime=Fri Feb 18 05:58:54 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193616, encodeId=d3b0119361668, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d585243593, createdName=光明骑士, createdTime=Tue Feb 15 14:29:24 CST 2022, time=2022-02-15, status=1, ipAttribution=)]
    2022-02-15 光明骑士

    学习

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

帕金森病(颤拘病)中医临床诊疗专家共识

广州中医药大学第二附属医院 · 2021-11-26

中西医结合治疗早期帕金森病专家共识(2021)

上海市中医药学会神经科分会 · 2021-11-02

2021 AAN实践指南：早期帕金森病运动症状的多巴胺能疗法

美国神经病学学会(AAN,American Academy of Neurology) · 2021-11-16

帕金森病冻结步态中西医诊治专家共识（2021）

中国神经内科相关专家小组（统称） · 2021-10-20

2021 多国共识：帕金森病吞咽困难的筛查、诊断和预后价值

国外神经内科相关专家小组（统称） · 2021-08-21

2021 多国专家共识：帕金森病吞咽困难的治疗

国外神经内科相关专家小组（统称） · 2021-09-27